Rare blood clots from AstraZeneca vaccine mostly affect younger people
By Clive Cookson & Anna Gross
AstraZeneca's vaccine has brought in $275 million in sales so far this year. (Published 2021)
By Rebecca Robbins
AstraZeneca Struggles With Data Needed for Covid-19 Vaccine's Approval - WSJ
By Jenny Strasburg & Thomas M. Burton
Spain extends AstraZeneca dose gap to 16 weeks, beyond EU approved limit
By Nathan Allen, john stonestreet & Inti Landauro
British regulator cites 41 more blood clot reports following AstraZeneca shots
By Bernadette Baum & Alistair Smout